OBERWEIS ASSET MANAGEMENT INC/ – Halozyme Therapeutics, Inc. Transaction History
OBERWEIS ASSET MANAGEMENT INC/ portfolio value:
$4.60M
portfolio value
OBERWEIS ASSET MANAGEMENT INC/ quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +13.09% | 13.49K shares | 74K | $39.54 | 116.54K |
| Q2 2022 | share | Decrease | -4.09% | -4.4K shares | 249K | $44 | 103.05K |
| Q1 2022 | share | Increase | +1.70% | 1.8K shares | 37K | $39.88 | 107.45K |
| Q4 2021 | share | Increase | +50.97% | 35.67K shares | 1.40M | $40.32 | 105.65K |
| Q3 2021 | share | Increase | +1.13% | 780 shares | -295K | $40.68 | 69.98K |
| Q2 2021 | share | Increase | +0.44% | 300 shares | 270K | $45.41 | 69.2K |
| Q1 2021 | share | Increase | 0.00% | 68.9K shares | 2.87M | $41.69 | 68.9K |